Neogen Chemicals closes QIP at ₹2,255 per share
As filed · Neogen Chemicals Limited has informed the Exchange about outcome of Fund Raising Committee Meeting held on September 16, 2026.
What happened
FactNeogen Chemicals closed its qualified institutions placement on September 16, 2026 after receiving applications and escrow funds for 26,60,753 equity shares from eligible qualified institutional buyers. The Fund-Raising Committee approved an issue price of ₹2,255 per share, including a premium of ₹2,245 per share, and finalized allocations.
Why it matters
CapitSignal interpretationA qualified institutional placement issues new shares, so existing holders own a smaller share of the same company unless the proceeds earn more than the dilution costs.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Capex
ContradictedPakhajan Phase 2 is budgeted at INR 1,367 crore with completion expected by March 2027
Dahej Phase 1 project cost stands at INR 428 crore with target completion by February 2027, while Pakhajan Phase 2 is budgeted at INR 1,367 crore with completion expected by March 2027
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Issue price versus the current market price
- Stated use of proceeds
- Resulting dilution as a percentage of equity
- 1,000 MT to be commissioned by H2 FY27 (management committed by H2 FY27)
- Looking ahead, as the replacement Dahej plant begins regular commercial operations and Neogen Ionics (NIL) cap (management committed by H2 FY27)
Evidence
- Neogen Chemicals Limited has informed the Exchange about outcome of Fund Raising Committee Meeting held on September 16, 2026.(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q4 FY26
How CapitSignal classified this
- Reasoning:
- The QIP adds new equity capital through institutional investors, while increasing the number of outstanding shares. The filing does not state the intended use of proceeds.
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%